The Covid-19 trans­genic cow an­ti­body start­up goes pub­lic in $325M SPAC merg­er

The trans­genic cows are go­ing pub­lic.

SAB Bio­ther­a­peu­tics, the Sioux Falls, SD com­pa­ny try­ing to ex­tract an­ti­body treat­ments from ge­net­i­cal­ly mod­i­fied cows, an­nounced Tues­day they …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER